Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
α-Galactosidase A is an acidic hydrolase that catalyzes the removal of terminal α-glucosidase groups from glycoproteins and glycolipids.1,2 It is ubiquitously expressed and functions as a homodimer with each monomer containing an N-terminal a(β/α)8 domain and a C-terminal anti-parallel β domain.3,1 Mutations in GLA, the gene encoding α-galactosidase A, induce lysosomal α-glucosidase A deficiencies, which cause Fabry disease, an X-linked lysosomal storage disorder characterized by hypohidrosis and heat intolerance, as well as cardiac, CNS, and vascular dysfunction.4,2 α-Galactosidase A activity is decreased in dried blood spots from patients with Parkinson's disease but not harboring the Parkinson's disease-associated mutations in LRRK2, LRRK2G2019S, or in glucocerebrosidase.5 Cayman’s α-Galactosidase A Rabbit Monoclonal Antibody (Clone 001) can be used for ELISA and immunoprecipitation (IP) applications.
WARNING This product is not for human or veterinary use.
1. Structure-
2. Affinity purification of human alpha galactosidase utilizing a novel small molecule biomimetic of alpha-
3. Human α-
4. Fabry’s disease — a comprehensive review on pathogenesis, diagnosis and treatment. J. Pak. Med. Assoc. 64(2), 189-194 (2014).
5. Alpha galactosidase A activity in Parkinson’s disease. Neurobiol. Dis. 112, 85-90 (2018).